Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

AMGN

AMGEN Inc.

May 03 • 04:00PM ET

311.29

Dollar change +32.90
Percentage change 11.82	%

Healthcare • Drug Manufacturers - General • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO QQQ SCHD IVV VTV VIG VYM IBB VHT

Scroll to Statements

Index	DJIA, NDX, S&P 500	P/E	44.51	EPS (ttm)	6.99	Insider Own	0.24%	Shs Outstand	535.40M	Perf Week	15.30%
Market Cap	166.83B	Forward P/E	15.05	EPS next Y	20.68	Insider Trans	-0.93%	Shs Float	534.62M	Perf Month	16.11%
Income	3.76B	PEG	8.49	EPS next Q	4.98	Inst Own	78.10%	Short Float	1.89%	Perf Quarter	-3.68%
Sales	29.35B	P/S	5.68	EPS this Y	4.61%	Inst Trans	-1.47%	Short Ratio	3.45	Perf Half Y	19.34%
Book/sh	9.36	P/B	33.25	EPS next Y	6.01%	ROA	4.14%	Short Interest	10.11M	Perf Year	35.75%
Cash/sh	18.11	P/C	17.18	EPS next 5Y	5.25%	ROE	72.57%	52W Range	211.71 - 329.72	Perf YTD	8.08%
Dividend Est.	9.30 (2.99%)	P/FCF	23.50	EPS past 5Y	-0.22%	ROI	5.78%	52W High	-5.59%	Beta	0.58
Dividend TTM	8.64 (2.78%)	Quick Ratio	0.98	Sales past 5Y	3.42%	Gross Margin	66.17%	52W Low	47.04%	ATR (14)	8.14
Dividend Ex-Date	May 16, 2024	Current Ratio	1.42	EPS Y/Y TTM	3.15%	Oper. Margin	29.34%	RSI (14)	78.56	Volatility	2.51% 1.99%
Employees	26700	Debt/Eq	12.75	Sales Y/Y TTM	13.18%	Profit Margin	12.82%	Recom	2.16	Target Price	313.89
Option/Short	Yes / Yes	LT Debt/Eq	11.96	EPS Q/Q	-103.99%	Payout	68.24%	Rel Volume	3.29	Prev Close	278.39
Sales Surprise	-0.06%	EPS Surprise	2.09%	Sales Q/Q	22.19%	Earnings	May 02 AMC	Avg Volume	2.93M	Price	311.29
SMA20	15.21%	SMA50	13.39%	SMA200	13.69%	Trades		Volume	9,615,730	Change	11.82%

Date	Action	Analyst	Rating Change	Price Target Change
Today	Upgrade	William Blair	Mkt Perform → Outperform
Today	Upgrade	Barclays	Underweight → Equal Weight	$230 → $300
Mar-28-24	Resumed	Raymond James	Mkt Perform
Feb-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$324 → $318
Dec-21-23	Upgrade	Daiwa Securities	Neutral → Buy	$264 → $320
Dec-19-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$286 → $326
Dec-12-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$256 → $300
Nov-09-23	Initiated	Deutsche Bank	Hold	$240
Nov-02-23	Upgrade	Truist	Hold → Buy	$260 → $320
Oct-20-23	Resumed	JP Morgan	Neutral	$265 → $270
Oct-17-23	Resumed	Morgan Stanley	Equal-Weight	$300
Oct-11-23	Resumed	BofA Securities	Neutral	$290
Sep-06-23	Initiated	HSBC Securities	Buy	$320
Apr-24-23	Reiterated	Oppenheimer	Outperform	$292 → $290
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$275 → $265
Feb-13-23	Reiterated	Truist	Buy	$280 → $260
Nov-18-22	Initiated	Credit Suisse	Underperform	$240
Oct-31-22	Downgrade	Barclays	Equal Weight → Underweight	$234
Oct-11-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$257 → $279
May-23-22	Initiated	SVB Leerink	Mkt Perform	$256

Show Previous Ratings

Today 06:15PM	Why Amgen Stock Zoomed Nearly 12% Higher Today (Motley Fool) +11.82%
05:07PM	Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market (Yahoo Finance)
04:51PM	These Stocks Moved the Most Today: Apple, Amgen, Expedia, Coinbase, Cloudflare, Fortinet, Live Nation, and More (Barrons.com)
04:49PM	S&P 500 Gains and Losses Today: Amgen Soars as Weight-Loss Drug Shows Promise (Investopedia)
04:04PM	Amgen Is 'Very Encouraged' With Its Obesity Drug. But Can It Take On Novo, Lilly Duopoly? (Investor's Business Daily)
03:46PM	Loading…
03:46PM	These Stocks Are Moving the Most Today: Apple, Amgen, Expedia, Coinbase, Cloudflare, Fortinet, Live Nation, and More (Barrons.com)
02:53PM	Analyst unveils Amgen stock price target after weight-loss drug data (TheStreet)
01:58PM	Sector Update: Health Care Stocks Mixed in Afternoon Trading (MT Newswires)
01:00PM	Interest rate cuts could switch from stroll to a sprint after US jobs surprise (The Telegraph)
12:53PM	Top Stock Movers Now: Apple, Amgen, Fortinet, and More (Investopedia)
12:31PM	Apple, Amgen rise; Expedia, Fortinet fall, Friday, 5/3/2024 (Associated Press Finance)
12:26PM	Stocks to Watch Friday: Amgen, Apple, Exxon (The Wall Street Journal)
12:14PM	Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition (MT Newswires)
12:13PM	US STOCKS-Wall St rallies after soft jobs data allays rate jitters (Reuters)
11:48AM	Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update (Zacks)
11:35AM	Loading…
11:35AM	Weight-loss drug competition heats up. Is Wegovy in trouble? (Yahoo Finance Video)
11:23AM	Amgen Inc. (NASDAQ:AMGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:51AM	Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying. (The Wall Street Journal)
10:43AM	Amgen teased trial results of its potential Ozempic competitor and the stock surged 13% (Quartz)
10:42AM	Amgen Stock Is Having Its Best Day Since 2009. Why Wall Street Is Excited About Its Weight-Loss Drug. (Barrons.com)
10:41AM	AMGN Stock Alert: Is Amgen the Next Hot Weight-Loss Drug Company? (InvestorPlace)
10:36AM	UBS Adjusts Price Target on Amgen to $307 From $284, Maintains Neutral Rating (MT Newswires)
10:31AM	US STOCKS-Wall St gains after soft jobs data allays rate jitters (Reuters)
10:28AM	Cramer's Mad Dash: Amgen (CNBC TV)
10:23AM	Deutsche Bank Adjusts Price Target on Amgen to $310 From $285, Hold Rating Maintained (MT Newswires)
10:11AM	Amgen surges over confidence in early obesity drug results (Yahoo Finance Video)
09:56AM	These Two Stocks Are Driving the Dow Friday (Barrons.com)
09:36AM	Amgen Soars as CEO Touts Experimental Obesity Drug Progress (Bloomberg)
09:32AM	Amgen upgraded, Peloton downgraded: Wall Street's top analyst calls (The Fly)
09:05AM	Sector Update: Health Care Stocks Mixed Pre-Bell Friday (MT Newswires)
08:58AM	Loading…
08:58AM	US STOCKS-Wall St set to open sharply higher on soft jobs data (Reuters)
08:48AM	Sector Update: Health Care (MT Newswires)
07:54AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:47AM	Novo Slides as Amgen Fuels Obesity Drug Competition Fears (Bloomberg)
07:31AM	Why Apples Nascent Rally Could Be Stalled By Warren Buffett (Barrons.com)
07:26AM	Arrowhead Nets $50 Milestone Payment from Royalty Pharma After Completion of Enrollment in Trial of Cardiovascular Drug (MT Newswires)
07:23AM	Amgen Stock Jumps on Obesity Drug Optimism. What Comes Next. (Barrons.com)
07:13AM	US STOCKS-Futures rise on Apple, Amgen boost; jobs data awaited (Reuters)
07:01AM	William Blair Upgrades Amgen to Outperform From Market Perform (MT Newswires)
06:54AM	Leerink Adjusts Price Target on Amgen to $352 From $324, Keeps Market Perform Rating (MT Newswires)
06:40AM	Update: Amgen Q1 Non-GAAP Earnings Decline, Revenue Increases; Adjusts Full-Year Guidance; Shares Advance Premarket (MT Newswires)
06:36AM	Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data (Reuters)
06:09AM	Futures rise on Apple, Amgen boost; jobs data awaited (Reuters)
06:05AM	US STOCKS-Futures rise on Apple, Amgen boost; jobs data on tap (Reuters)
05:44AM	BMO Capital Adjusts Price Target on Amgen to $355 From $336, Keeps Outperform Rating (MT Newswires)
05:43AM	RBC Adjusts Price Target on Amgen to $328 From $332, Keeps Outperform Rating (MT Newswires)
05:43AM	Morgan Stanley Adjusts Price Target on Amgen to $310 From $271, Keeps Equalweight Rating (MT Newswires)
05:42AM	Goldman Sachs Adjusts Price Target on Amgen to $350 From $359, Keeps Buy Rating (MT Newswires)
05:42AM	Amgen shares jump after teasing weight-loss drug data, rivals slip (Reuters)
05:41AM	Barclays Upgrades Amgen to Equalweight From Underweight, Adjusts Price Target to $300 From $230 (MT Newswires)
05:28AM	These Stocks Are Moving the Most Today (Barrons.com)
03:57AM	Amgen Inc (AMGN) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic Advances (GuruFocus.com)
May-02-24 10:10PM	Amgen Stock Surges After Q1 Earnings Beat, 'Encouraging' Weight-Loss Drug Update (Investopedia)
08:59PM	AMGN Stock Earnings: Amgen Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:00PM	Here's What Key Metrics Tell Us About Amgen (AMGN) Q1 Earnings (Zacks)
05:50PM	Amgen axes obesity asset after phase 1 results, zooms in on MariTide (FierceBiotech.com)
05:42PM	Amgen Inc (AMGN) Q1 2024 Earnings: Aligns with EPS Projections Amid Revenue Growth and Challenges (GuruFocus.com)
05:21PM	Amgen, DraftKings, Live Nation: Trending tickers (Yahoo Finance Video)
04:45PM	Amgen Q1 Non-GAAP Earnings Decline, Revenue Increases; Adjusts Full-Year Guidance; Shares Advance After Hours (MT Newswires)
04:33PM	UPDATE 1-Amgen first-quarter profit dips 1%, revenue rises 22% (Reuters)
04:24PM	Amgen Surges On Strong First-Quarter Profit As Obesity Space Heats Up (Investor's Business Daily)
04:24PM	Amgen Beats First-Quarter Expectations, But Shares Slide As Investors Watch Obesity Space (Investor's Business Daily)
04:09PM	Amgen: Q1 Earnings Snapshot (Associated Press Finance)
04:02PM	Amgen 'encouraged' by weight-loss drug interim data, shares jump (Reuters)
04:01PM	Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma (Business Wire)
04:01PM	AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS (PR Newswire)
04:01PM	Amgen first-quarter profit dips 1%, revenue rises 22% (Reuters)
May-01-24 03:00PM	Ticking Time Bombs: 3 Dow Stocks to Dump While You Still Can (InvestorPlace)
11:11AM	Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:04AM	Amgen investors await weight-loss drug data (Reuters)
07:00AM	AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024 (PR Newswire)
Apr-30-24 01:54PM	Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab (Benzinga)
12:05PM	Microsoft Corporation (NASDAQ:MSFT) Q3 2024 Earnings Call Transcript (Insider Monkey)
09:20AM	Sector Update: Health Care Stocks Mixed Premarket Tuesday (MT Newswires)
05:58AM	Amgen Reaches Deal to Resolve Patent Disputes With Sandoz (MT Newswires)
01:28AM	Sandoz reaches agreement with Amgen over patent dispute (Reuters)
Apr-29-24 04:00PM	AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTS (PR Newswire)
12:35PM	What's in the Cards for Amgen (AMGN) This Earnings Season? (Zacks)
09:16AM	Insights Into Amgen (AMGN) Q1: Wall Street Projections for Key Metrics (Zacks)
Apr-28-24 08:00AM	What To Expect in the Markets This Week (Investopedia)
Apr-26-24 06:17PM	A Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed (Investor's Business Daily)
11:00AM	Amgen to Submit Thyroid Eye Disease Treatment Marketing Authorization Application in Europe (MT Newswires)
09:00AM	AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY (PR Newswire)
Apr-25-24 01:30PM	CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript (Insider Monkey)
11:34AM	20 Fastest Growing Health Tech Companies in the World (Insider Monkey)
10:02AM	Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-22-24 05:50PM	Why Amgen (AMGN) Outpaced the Stock Market Today (Zacks)
11:10AM	10 Best Performing Biotech ETFs in 2024 (Insider Monkey)
Apr-19-24 07:14AM	The Dividend Goldmine: 3 Shining Stocks With Growing Payouts (InvestorPlace)
Apr-17-24 06:00PM	Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
08:00AM	Sell These 3 Blue-Chip Stocks Before the Next Earnings Stumble (InvestorPlace)
08:00AM	Coming FDA Approvals Could Send These 3 Drug Stocks Soaring (InvestorPlace)
07:30AM	Can This High-Yield Dividend Stock Keep Beating the S&P 500? (Motley Fool)
04:30AM	Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever (Motley Fool)
Apr-16-24 05:26PM	AMGEN TO PRESENT TEZSPIRE PHASE 2A COPD DATA AT ATS 2024 (PR Newswire)
04:30PM	The 3 Best Biotech Stocks to Buy Now: Q2 Edition (InvestorPlace)
Apr-15-24 03:07PM	3 Stocks to Buy Low Today With High Hopes for Tomorrow (InvestorPlace)
09:07AM	Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Apr-13-24 12:18PM	Jim Cramer's 10 Favorite Healthcare Stock Picks in 2024 (Insider Monkey)
Apr-12-24 02:48PM	Final Trades: Shell, 2-YR T-Note and Amgen (CNBC TV)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grygiel Nancy A.	SVP & CCO	Dec 04 '23	Sale	273.03	2,096	572,276	10,874	Dec 04 07:41 PM
Graham Jonathan P	EVP, Gen. Counsel & Secy.	Nov 08 '23	Sale	272.81	10,000	2,728,136	28,078	Nov 13 08:30 PM
AMGEN INC	10% Owner	Sep 19 '23	Buy	17.00	1,764,705	29,999,985	35,368,653	Sep 19 07:52 PM
Gordon Murdo	EVP, Global Commercial Ops	Aug 10 '23	Sale	262.43	9,558	2,508,306	44,308	Aug 11 06:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc.

Upgrade your FINVIZ experience